Collectively, these findings are consistent with the elevated plasma levels of inflammatory markers observed in COVID-19 patients [44,45], where the profile of IL-6, CCL2/MCP-1, and CXCL10/IP-10 are associated with the severity of the disease [46]. This evidence concerns the gene CXCL10 and COVID-19.